Life Tech: Adding value to clones

In the post-genomics world, researchers increasingly have free access to information such as gene sequences that both for-profit and not-for-profit entities have obtained at significant trouble and expense. How to make money from sequence information is a cloudy issue. Life Technologies Inc., a research supply company that produces cDNA libraries, is capitalizing on making full-length gene sequences publicly